Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ILMN Illumina > Main Composition
ILMN Illumina
209.910
-0.510-0.24%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Core Illumina--4.52B99.85%
GRAIL--12M0.27%
Eliminations---5M-0.11%
Region Unit:USD
nameYOYOperating income%
United States--2.2B48.50%
Europe, Middle East, and Africa--1.29B28.48%
Greater China--502M11.09%
Asia-Pacific--377M8.33%
Americas--163M3.60%
Company Overview More
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
CEO: Mr. Francis A. DeSouza
Market: NASDAQ
Listing Date: 07/28/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist